B4RMG2 AF NFT

Dual-specificity RNA methyltransferase RlmN

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeigyusosboms5mqifkwojhrj7yap4z2cizo2angxvp2zdbffhtpegi/metadata.json
IPFS of structure file: 
bafybeiehfkypoqjt4rjgqhjj6abt3cwmqwkg7tvm5k37jjnoorc6t4ley4/AF-B4RMG2-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x5DC8e905727f28f8E14d8601Ab9daaa77d7eaB40
First NFT owner address (bech32): 
genesis1thywjptj0u503c2dscq6h8d25a7ha26qdgct27
Current NFT ID #378390 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
378390
Accession (UniProt):
B4RMG2
Name::
Dual-specificity RNA methyltransferase RlmN
Experimental Method:
Predicted structure
Sequence source:
NEISSERIA GONORRHOEAE (STRAIN NCCP11945)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT B4RMG2 research and analysis (ICN3D with VR)

FASTA sequences

>sp|B4RMG2|RLMN_NEIG2 Dual-specificity RNA methyltransferase RlmN OS=Neisseria gonorrhoeae (strain NCCP11945) OX=521006 GN=rlmN PE=3 SV=1 MKTNLLNYDLQGLTRHFADMGEKPFRAKQVMRWMHQSGAQNFDEMTDLAKSLRHKLNEQASIEIPKLMMSQESSDGTRKWLLDVGTGNGVETVFIPESDRGTLCISSQVGCALECTFCSTGRQGFNRNLTAAEIIGQLWWANKAMGVTPKNERVISNVVMMGMGEPMANFDNVVTALSIMLDDHGYGLSRRRVTVSTSGMVPQMDRLRDVMPVALAVSLHASNDEVRNQIVPLNKKYPLKELMAACQRYLVKAPRDFITFEYVMLDGVNDKAQHAYELIELVKDVPCKFNLIPFNPFPNSGYERSSNENIRIFRDILQQAEFVVTVRKTRGDDIDAACGQLAGQVQDKTRRQQKWQQILIGQQG